End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 NZD | +1.75% | -0.47% | -3.33% |
Mar. 08 | New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire | MT |
Mar. 08 | Fisher & Paykel Healthcare's Chair to Retire | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For several months, analysts have been revising their EPS estimates roughly upwards.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an expected P/E ratio at 27.79 and 30.06 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.63 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company is highly valued given the cash flows generated by its activity.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Electric Utilities
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.33% | 5.22B | B- | ||
+10.50% | 86.11B | B | ||
-11.86% | 16.76B | C+ | ||
+48.92% | 11.24B | D+ | ||
+10.78% | 11.07B | C+ | ||
-16.86% | 10.36B | B | ||
+8.30% | 9.12B | B- | ||
+13.90% | 6.73B | C+ | ||
+1.01% | 4.44B | - | ||
-.--% | 3.79B | - | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MCY Stock
- Ratings Mercury NZ Limited